<SEC-DOCUMENT>0001104659-21-082753-index.html : 20210625
<SEC-HEADER>0001104659-21-082753.hdr.sgml : 20210625
<ACCEPTANCE-DATETIME>20210617181355
ACCESSION NUMBER:		0001104659-21-082753
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20210728
FILED AS OF DATE:		20210621
DATE AS OF CHANGE:		20210617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics plc
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		211026242

	BUSINESS ADDRESS:	
		STREET 1:		56 FITZWILLIAM SQUARE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		(610) 816-6640

	MAIL ADDRESS:	
		STREET 1:		1000 CONTINENTAL DRIVE
		STREET 2:		SUITE 600
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nabriva Therapeutics AG
		DATE OF NAME CHANGE:	20150507
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>tm2119969-1_pre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
Document 1 - file: tm2119969-1_pre14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_nabrivanew-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_nabrivanew-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>sg_danburgess-bwg.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: sg_danburgess-bwg.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2119969d1_proxypg1-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tm2119969d1_proxypg1-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2119969d1_proxypg2-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tm2119969d1_proxypg2-4c.jpg

</DOCUMENT>
</SEC-DOCUMENT>